Profile


Research Training in Nephrology
07/01/1975 - 06/30/2005 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 T32 DK07053 31

Case Mix Models for End Stage Renal Disease Patients
07/31/1996 - 06/30/2001 (Dept Sponsor)
NIH/National Diabetes & Digestive & Kidney Diseases
5 K08 DK02453 05


Detection of Anti- Fabrazyme Antiboty in Kidney Biopsy Sample
06/21/2018 - 06/21/2021 (PI)
Genzyme Corp

Research Training in Nephrology
07/01/2015 - 06/30/2020 (PI)
NIH-NIDDK
5T32DK007053-43

Role of PLA2R and Anti-PLA2R in Idiopathic Membranous Nephropathy
09/01/2011 - 07/31/2017 (PI)
NIH-NIDDK
5R01 DK090029-05

Alnylam Sponsored Research Agreement
05/07/2014 - 05/31/2016 (PI)
Alnylam Pharmaceuticals

Efficacy of Targeted Complement Regulatory Proteins in Experimental Membranous Nephropathy
01/01/2013 - 11/30/2015 (PI)
Alexion Pharmaceuticals

Research Training in Nephrology
07/01/2010 - 06/30/2015 (PI)
NIH-NIDDK
5T32DK007053-41

Anti-PLA2R Immunoreactivity
05/18/2009 - 05/31/2013 (PI)
Questcor Pharmaceuticals, Inc.

Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy
07/02/2010 - 06/30/2012 (PI)
NIH-NIAID
1R21 AI090238-02

Antibody Mediated Glomerular Injury
03/01/2006 - 12/31/2011 (PI)
NIH-NIDDK
5R01 DK030932-26

Research Training in Nephrology
07/01/2005 - 06/30/2010 (PI)
NIH-NIDDK
5 T32 DK007053-36

Showing 10 of 20 results. Show All Results


Yr Title Project-Sub Proj Pubs
2016 Research Training in Nephrology 5T32DK007053-43 43
2015 Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy 5R01DK090029-05 18
2015 Research Training in Nephrology 2T32DK007053-42 43
2014 Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy 5R01DK090029-04 18
2014 Research Training in Nephrology 5T32DK007053-41 43
2014 Research Training in Nephrology 5T32DK007053-41 43
2013 Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy 5R01DK090029-03 18
2013 Research Training in Nephrology 5T32DK007053-40 43
2012 Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy 5R01DK090029-02 18
2012 Research Training in Nephrology 5T32DK007053-39 43
Showing 10 of 67 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Belghasem ME, A'amar O, Roth D, Walker J, Arinze N, Richards SM, Francis JM, Salant DJ, Chitalia VC, Bigio IJ. Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy. Sci Rep. 2019 May 09; 9(1):7168.View Related Profiles. PMID: 31073168.
     
  2. Salant DJ. Unmet challenges in membranous nephropathy. Curr Opin Nephrol Hypertens. 2019 01; 28(1):70-76. PMID: 30451735.
     
  3. Kasinath V, Yilmam OA, Uehara M, Jiang L, Ordikhani F, Li X, Salant DJ, Abdi R. Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis. Kidney Int. 2019 02; 95(2):310-320. PMID: 30522766.
     
  4. Beck LH, Salant DJ. Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele. Kidney Int. 2018 11; 94(5):855-857.View Related Profiles. PMID: 30348302.
     
  5. Estrada CC, Paladugu P, Guo Y, Pace J, Revelo MP, Salant DJ, Shankland SJ, D'Agati VD, Mehrotra A, Cardona S, Bialkowska AB, Yang VW, He JC, Mallipattu SK. Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation. JCI Insight. 2018 Jun 21; 3(12). PMID: 29925693; DOI: 10.1172/jci.insight.98214;.
     
  6. Caster DJ, Korte EA, Tan M, Barati MT, Tandon S, Creed TM, Salant DJ, Hata JL, Epstein PN, Huang H, Powell DW, McLeish KR. Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis. Am J Physiol Renal Physiol. 2018 09 01; 315(3):F595-F606. PMID: 29790391.
     
  7. Kolachalama VB, Singh P, Lin CQ, Mun D, Belghasem ME, Henderson JM, Francis JM, Salant DJ, Chitalia VC. Association of Pathological Fibrosis With Renal Survival Using Deep Neural Networks. Kidney Int Rep. 2018 Mar; 3(2):464-475.View Related Profiles. PMID: 29725651.
     
  8. Larsen CP, Trivin-Avillach C, Coles P, Collins AB, Merchant M, Ma H, Wilkey DW, Ambruzs JM, Messias NC, Cossey LN, Rosales IA, Wooldridge T, Walker PD, Colvin RB, Klein J, Salant DJ, Beck LH. LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease. J Am Soc Nephrol. 2018 02; 29(2):644-653.View Related Profiles. PMID: 29074737.
     
  9. Korte EA, Caster DJ, Barati MT, Tan M, Zheng S, Berthier CC, Brosius FC, Vieyra MB, Sheehan RM, Kosiewicz M, Wysoczynski M, Gaffney PM, Salant DJ, McLeish KR, Powell DW. ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation. Am J Pathol. 2017 Dec; 187(12):2799-2810. PMID: 28935578.
     
  10. Al-Rabadi L, Quillen K, Shashar M, Al Marji C, Jaberi A, Chitalia V, Henderson J, Salant D, Beck LH. Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy. Kidney Int Rep. 2018 Mar; 3(2):476-481.View Related Profiles. PMID: 29725652.
     
Showing 10 of 163 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: